Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence.

about

Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.

P2860

Q47162410-5DF83F0B-DFEE-4CEB-939E-0764361D7EA1

P2860

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence.

Item

http://www.wikidata.org/entity/Q35884179

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Relationship Between Sunitinib ...... linical and Clinical Evidence.

@ast

Relationship Between Sunitinib ...... linical and Clinical Evidence.

@en

type

Item

label

Relationship Between Sunitinib ...... linical and Clinical Evidence.

@ast

Relationship Between Sunitinib ...... linical and Clinical Evidence.

@en

prefLabel

Relationship Between Sunitinib ...... linical and Clinical Evidence.

@ast

Relationship Between Sunitinib ...... linical and Clinical Evidence.

@en

P1476

Relationship Between Sunitinib ...... clinical and Clinical Evidence

@en

P2093

Annelieke S de Wit

http://www.w3.org/2001/XMLSchema#string

Herman Burger

http://www.w3.org/2001/XMLSchema#string

Ines Chaves

http://www.w3.org/2001/XMLSchema#string

Jacqueline S L Kloth

http://www.w3.org/2001/XMLSchema#string

Lisette Binkhorst

http://www.w3.org/2001/XMLSchema#string

Mei H Lam

http://www.w3.org/2001/XMLSchema#string

Paul Hamberg

http://www.w3.org/2001/XMLSchema#string

Peter de Bruijn

http://www.w3.org/2001/XMLSchema#string

Ron H J Mathijssen

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.

Clinical pharmacokinetics of tyrosine kinase inhibitors.

Molecular basis for sunitinib efficacy and future clinical development.

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.

P2888

s40262-015-0239-5

P304

851-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40262-015-0239-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik Wiemer

Gijsbertus van der Horst

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273954797

http://www.w3.org/2001/XMLSchema#string

P698

25647628

http://www.w3.org/2001/XMLSchema#string

P932

4513224

http://www.w3.org/2001/XMLSchema#string

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence.

about

P2860

P2860

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932